Brian Adams Relay Therapeutics, Inc. (RLAY) insider trading activity

Brian Adams is Chief Legal Officer of Relay Therapeutics, Inc.. Currently has a direct ownership of 405,972 shares of RLAY, which is worth approximately $1.04 Million. The most recent transaction as insider was on Sep 27, 2022, when has been sold 294 shares (Common Stock) at a price of $22.73 per share, resulting in proceeds of $6,683. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 406K

26.23% 3M change

24.0% 12M change

Total Value Held $1.04 Million

Brian Adams Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 27 2022	SELL Open market or private sale	$6,683 $22.73 p/Share	294 Reduced 0.47%	62,548 Common Stock
Jul 28 2022	SELL Open market or private sale	$15,612 $21.27 p/Share	734 Reduced 1.15%	62,842 Common Stock
Jun 27 2022	SELL Open market or private sale	$6,093 $20.31 p/Share	300 Reduced 0.47%	63,576 Common Stock
Apr 28 2022	SELL Open market or private sale	$18,104 $25.57 p/Share	708 Reduced 1.1%	63,876 Common Stock
Mar 29 2022	SELL Open market or private sale	$9,947 $29.87 p/Share	333 Reduced 0.51%	64,584 Common Stock
Jan 27 2022	BUY Grant, award, or other acquisition	-	39,270 Added 37.69%	64,917 Common Stock
Dec 31 2021	BUY Grant, award, or other acquisition	$17,174 $26.1 p/Share	658 Added 2.5%	25,647 Common Stock
Dec 27 2021	SELL Open market or private sale	$9,764 $33.1 p/Share	295 Reduced 1.17%	24,989 Common Stock
Nov 15 2021	SELL Open market or private sale	$230,230 $35.42 p/Share	6,500 Reduced 20.45%	25,284 Common Stock
Nov 15 2021	BUY Exercise of conversion of derivative security	$26,780 $4.12 p/Share	6,500 Added 16.98%	31,784 Common Stock
Sep 27 2021	SELL Open market or private sale	$10,803 $36.87 p/Share	293 Reduced 1.15%	25,284 Common Stock
Sep 13 2021	SELL Open market or private sale	$227,630 $35.02 p/Share	6,500 Reduced 20.26%	25,577 Common Stock
Sep 13 2021	BUY Exercise of conversion of derivative security	$26,780 $4.12 p/Share	6,500 Added 16.85%	32,077 Common Stock
Jun 28 2021	SELL Open market or private sale	$10,492 $35.81 p/Share	293 Reduced 1.13%	25,577 Common Stock
Jun 07 2021	SELL Open market or private sale	$227,500 $35.0 p/Share	6,500 Reduced 20.08%	25,870 Common Stock
Jun 07 2021	BUY Exercise of conversion of derivative security	$26,780 $4.12 p/Share	6,500 Added 16.72%	32,370 Common Stock
Apr 26 2021	SELL Open market or private sale	$227,500 $35.0 p/Share	6,500 Reduced 20.08%	25,870 Common Stock
Apr 26 2021	BUY Exercise of conversion of derivative security	$26,780 $4.12 p/Share	6,500 Added 16.72%	32,370 Common Stock
Mar 26 2021	BUY Grant, award, or other acquisition	-	15,870 Added 38.02%	25,870 Common Stock
Jan 28 2021	SELL Open market or private sale	$275,250 $55.05 p/Share	5,000 Reduced 33.33%	10,000 Common Stock
Jan 28 2021	BUY Exercise of conversion of derivative security	$20,600 $4.12 p/Share	5,000 Added 25.0%	15,000 Common Stock

Brian Adams

Chief Legal Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RLAY shares.

Notify only if

Value

Insider Trading

Get notified when an Relay Therapeutics, Inc. insider buys or sells RLAY shares.

Notify only if

Operation

Value

Type

News

Receive news related to Relay Therapeutics, Inc.

Track Activities on RLAY

Account